J9358 HCPCS code: Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
J9358 is the HCPCS Level II code for injection, fam-trastuzumab deruxtecan-nxki, 1 mg. In 2024 Medicare paid an average of $21.26 per service for J9358 across 8,036,383 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1000 per day on DME suppliers. Medicare volume rose 103% from 2022 to 2024 (3,955,843 to 8,036,383 services). In 2024, about 2,789 clinicians billed Medicare for J9358 for 3,150 beneficiaries; California, Texas, Florida accounted for 31% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2020-07-01 |
| Last action effective | 2020-07-01 |
Who bills J9358 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,789 |
| Medicare beneficiaries | 3,150 |
| States with claims | 40 |
| Share of services in top 3 states (California, Texas, Florida) | 31% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9358, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 3,955,843 | 1,851 | $24.22 | $19.33 |
| 2023 | 6,954,318 | 2,769 | $25.20 | $20.07 |
| 2024 | 8,036,383 | 3,150 | $26.68 | $21.26 |
States with the most J9358 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 1,011,498 | $21.37 |
| Texas | 744,761 | $21.51 |
| Florida | 724,067 | $20.97 |
| Illinois | 408,847 | $21.24 |
| Maryland | 360,544 | $21.25 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 1000 | CMS Policy |
| outpatient hospital claims | 1000 | CMS Policy |
| practitioner claims | 1000 | CMS Policy |
What changed for J9358
- 2020-07-01: J9358 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9358?
J9358 is the HCPCS Level II code for injection, fam-trastuzumab deruxtecan-nxki, 1 mg. Short descriptor: "Inj fam-trastu deru-nxki 1mg".
How much does Medicare pay for J9358?
In 2024, the average Medicare payment was $21.26 per service (average allowed $26.68).
Does Medicare cover J9358?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9358 can be billed per day?
1000 on DME suppliers; 1000 on outpatient hospital claims; 1000 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9358
- Watch J9358 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9358
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.